Cancer Chemo Flashcards
Microtubule inhibitor that causes peripheral neuropathy, foot drop (eg. ataxia), and “pins and needles” sensation
Vincristine
Anti-estrogen used for estrogen receptor + breast cancer
Tamoxifen
Side effect of Mitomycin
SEVERE myelosuppression
Toxic effect of anticancer drug can be lessened by rescue agents
Rescue therapy
Treatment with cancer chemotherapy at high doses every 3-4 weeks, too toxic to be used continuously
Pulse therapy
Alkylating agent that produces disulfiram-like reaction with ethanol
Procarbazine
Drug used in cancer therapy causes Cushing-like symptoms
Prednisone
Binds tubulin and prevents the disassembly of microtubules during the M phase of the cell cycle inducing mitotic arrest
Paclitaxel (taxol)
Anti-emetics used in association with anti-cancer drugs that are 5-HT3 (serotonin receptor subtype ) antagonist
Odansetron, granisetron, dolasetron, palonosetron
Common toxicities of cisplatin
Nephro and ototoxicity
MOPP regimen used in Hodgkin’s disease (HD)
Mechlorethamine+ oncovorin (vincristine)+ procarbazine, and prednisone
Alkylating agent, vesicant that causes tissue damage with extravasation
Mechlorethamine
Constant proportion of cell population killed rather than a constant number
Log-kill hypothesis
Converts asparagine to aspartate and ammonia, denies cancer cells of essential AA (asparagine)
L-asparaginase
Used for hairy cell leukemia; it stimulates NK cells
Interferon alpha
Prevention of cyclophosphamide induced hemorrhagic cystitis
Hydration and mercaptoethanesulfonate (MESNA)
Anti-androgen used for prostate cancer
Flutamide (Eulexin)
May protect against doxorubicin cardio-toxicity by chelating iron
Dexrazoxane
Anticancer drug also used in RA, produces acrolein in urine that leads to hemorrhagic cystitis
Cyclophosphamide
Regimen used for breast cancer
CMF (cyclophosphamide, methotrexate, and fluorouracil) and tamoxifen if ER+
Toxicities include nephrotoxicity and ototoxicity, leading to a severe interaction with aminoglycosides
Cisplatin
Regimen used for non-Hodgkin’s lymphoma
CHOP (cyclophosphamide, oncovin(vincristine), doxorubicin and prednisone), rituximab (rituxan)
Nitrosoureas with high lipophilicity, used for brain tumors
Carmustine (BCNU) and lomustine (CCNU)
Agent similar to cisplatin, less nephrotoxic, but greater myelosuppression
Carboplatin
Some cell cycle specific anti-cancer drugs
Bleomycin, vinca alkaloids, antimetabolites (eg., 5-FU, 6-MP, methotrexate, etoposide)
Blows DNA (breaks DNA strands), limiting SE is pulmonary fibrosis
Bleomycin
Drug used concurrently with toxic anticancer agents to reduce renal precipitation of urates
Allopurinol
Interaction with this drug requires dose reduction of 6-MP
Allopurinol
Some cell cycle non-specific drugs
Alkylating agents (eg., mechlorethamine, cyclophosphamide), antibiotics (doxorubicin, daunorubicin), cisplatin, nitrosourea
MOA of cisplatin
Alkylating agent
Analog of hypoxanthine, needs HGPRTase for activation
6-mercaptopurine (6-MP)
Pyrimidine analog that causes “Thiamine-less death” given with leucovorin rescue
5-flouracil (5-FU)